Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs

Patent No. EP2345425 (titled "Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs") was filed by Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Dec 26, 2006. The application was issued on Jul 11, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
OCTAPHARMAApr 11, 2019ULLRICH & NAUMANN PARTG MBB
TAKEDA PHARMACEUTICALSApr 11, 2019HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2345425

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP11162751A
Filing Date
Dec 26, 2006
Status
Revoked
Jun 25, 2021
Publication Date
Jul 11, 2018